Yu Chang
-
- Lymphoma Diagnosis and Treatment 38
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 5
- Biomaterials top 5%
- Oncology top 5%
- Viral-associated cancers and disorders 14
- Cancer-related Molecular Pathways 6
- CAR-T cell therapy research 5
- Immunology top 10%
- Immune Cell Function and Interaction 11
-
- CNS Lymphoma Diagnosis and Treatment 8
-
- Nanoplatforms for cancer theranostics 6
- Journals
- Scientific Reports (4 papers)Cancer Management and Research (3 papers)Annals of Hematology (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yu Chang
92 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Pathology and Forensic Medicine 611
- Cancer Research 430
- Biomaterials 357
- Oncology 684
- Immunology 424
Countries citing papers authored by Yu Chang
This map shows the geographic impact of Yu Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Chang more than expected).
Fields of papers citing papers by Yu Chang
This network shows the impact of papers produced by Yu Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Chang. The network helps show where Yu Chang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yu Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 27 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 0 | |
| 8 | 2021 | 2 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 10 | |
| 11 | Clinical features and prognostic factors of primary bone marrow lymphoma | 2019 | 2 |
| 12 | 2019 | 14 | |
| 13 | 2019 | 7 | |
| 14 | 2017 | 2 | |
| 15 | 2017 | 21 | |
| 16 | 2015 | 11 | |
| 17 | 2014 | 0 | |
| 18 | 2013 | 82 | |
| 19 | Analysis of HBV Infection in Non-Hodgkin Lymphoma | 2009 | 1 |
| 20 | 1999 | 11 |
About Yu Chang
Yu Chang is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 96 papers that have together received 2.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (38 papers), Viral-associated cancers and disorders (14 papers), Immune Cell Function and Interaction (11 papers), CNS Lymphoma Diagnosis and Treatment (8 papers), Cancer-related Molecular Pathways (6 papers), Nanoplatforms for cancer theranostics (6 papers), Cancer-related molecular mechanisms research (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (611 citations), Cancer Research (430 citations) and Biomaterials (357 citations). Yu Chang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jun Lin, Ping’an Ma, Ziyong Cheng, Xinyang Zhang, Haihua Xiao, Jianhua Liu, Zhen Gu, Jinqiang Wang, Haiqin Song and Chunxia Li. Their work appears in journals such as Scientific Reports, Cancer Management and Research, Annals of Hematology, Oncology Reports and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.